We are deeply saddened by this tragedy and want to express our condolences to the family of the deceased and those affected by this tragedy. We are working closely with Sellen Construction, Edmonds Police Department, Snohomish County Fire District 1, and Labor & Industries to investigate the accident and determine what happened.
Although the accident resulted in temporary disruption of power at some of the outlying buildings on the Swedish Edmonds campus, no care services at the main hospital were impacted aside from a temporary safety pause for cardiac cath lab and some elective procedure patients. Power was completely restored to the campus by 3:45 pm.
Out of respect for the family of the victim, those affected by the accident and the ongoing investigation, Swedish cannot provide additional comment at this time.
Pacific Cancer Research Consortium Receives $6.6 Million Grant to Expand Access to Oncology Care, Trials
Consortium includes Swedish Cancer Institute, Providence Portland Medical Center and St. Luke’s Mountain States Tumor Institute
FOR IMMEDIATE RELEASE
Contacts: Clay Holtzman, Swedish Cancer Institute, 206-386-2748, firstname.lastname@example.org
Jean Marks, Providence Portland Medical Center, 503-215-6433, email@example.com
Ken Dey, St. Luke’s Mountain State Tumor Institute, 208-381-2894, firstname.lastname@example.org
SEATTLE — August 5, 2014 — The National Cancer Institute’s Community Oncology Research Program (NCORP) has awarded a consortium of community cancer centers from the Western United States a five-year grant worth $6.6 million to improve access to lifesaving cancer care and clinical trials across a five-state region.
The Pacific Cancer Research Consortium is led by three primary sites: the Swedish Cancer Institute (SCI) in Seattle, which will serve as the grant’s fiduciary, Providence Portland Medical Center (PPMC) in Oregon and St. Luke’s Mountain States Tumor Institute (MSTI) in Boise, Idaho. The consortium also includes 37 other clinical care sites in Alaska, California, Idaho, Oregon and Washington. The program opened on Aug. 4.
The Consortium’s grant is part of a $93 million funding cycle announced today by NCORP and awarded to 53 researchers across the country.
“We are extremely honored that the National Cancer Institute Community Oncology Research Program has selected our consortium to lead the expansion of cancer clinical trials throughout the Western region,” said Thomas Brown, M.D., executive director of the Swedish Cancer Institute. “Together Swedish Cancer Institute, Providence Cancer Center at Providence Portland Medical Center, St. Luke’s Mountain States Tumor Institute, and a network of clinical care sites are giving patients and their families access to the most current investigational therapies that give hope to advancing the care of cancer patients throughout our region and beyond. Access to clinical trials is the key to providing high quality cancer care in the 21st century.”
Swedish Cancer Institute’s Henry Kaplan, M.D., co-published and helped fund new study
Contact: RSNA Media Relations: 1-630-590-7762
Swedish Cancer Institute, Clay Holtzman, (206) 386-2748, email@example.com
OAK BROOK, Ill. – Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases, according to a new study published online in the journal Radiology. Researchers said the findings lend support to regular mammography screening in women ages 75 and older.
The value of mammography screening in older women has been subject to much debate in recent years. The American Cancer Society recommends annual mammograms for women age 75 and older as long as they are in good health, while the U.S. Preventive Services Task Force (USPSTF) does not recommend mammography screening in this age group, citing insufficient evidence to evaluate benefits and harms.
A lack of research is chiefly responsible for the divergent recommendations, according to Judith A. Malmgren, Ph.D., affiliate assistant professor at the University of Washington’s School of Public Health and Community Medicine in Seattle.
“There are no studies on women age 75 and older, despite the fact that they are at the highest risk for breast cancer,” she said.
Dr. Malmgren and her research partner, Henry Kaplan, M.D., from the Swedish Cancer Institute in Seattle, recently looked at the impact of mammography detection on older women by studying data from an institutional registry that includes more than 14,000 breast cancer cases with 1,600 patients over age 75.
Swedish Launches Studies Examining Focused Ultrasound as a Potential Treatment for Parkinson’s disease, Brain Tumors
Swedish Neuroscience Institute leads national ultrasound technology research
FOR IMMEDIATE RELEASE
Contact: Clay Holtzman, Swedish, (206) 998-5028, firstname.lastname@example.orgSEATTLE — July 30, 2014 — The Swedish Neuroscience Institute (SNI) is expanding its study of focused ultrasound as a novel treatment for brain disorders with the opening of two clinical trials examining the treatment of Parkinson’s disease and brain tumors. The new trials add to the institute’s ongoing study of focused ultrasound for a treatment of essential tremor (ET).
“SNI is one of the few locations in the world where focused ultrasound is being studied at this level. These efforts exemplify SNI’s ongoing mission to deliver leading edge treatment for brain and spinal conditions,” said David Newell, M.D., Chief of Neurosciences at SNI. “We are honored to be a pioneer in this field and are eager to produce translational results.”
These trials come after SNI launched a study last year examining focused ultrasound’s potential as a treatment for essential tremor, a common neurological disorder resulting in involuntary shaking. The original study was designed to determine viability and safety of ultrasound treatment in improving the quality of life for those affected. Together, these three studies place SNI at the forefront of clinical care providers studying focused ultrasound as a treatment approach.
Two of the three North Sound public district hospitals, who formed a consortium called the Interlocals, announced a decision today to explore a formal affiliation with PeaceHealth and UW Medicine. Skagit Regional Health and Cascade Valley Hospital will pursue the affiliation. Island Hospital announced it will not pursue an affiliation at this time.
SEATTLE, August 16, 2013 - Now in its 13th year, Seattle magazine recently published the results of their annual 'Top Doctors' survey in the July issue. As in past years, dozens of Swedish-affiliated (or credentialed) physicians were recognized in the popular issue due to being nominated by their peers.
Additionally, Seattle Metropolitan magazine published the results of its 'Top Doctors' survey in the August issue, in which dozens of Swedish-affiliated (or credentialed) physicians were also featured
Swedish is again recognized as one of the leading hospital systems in Washington State as part of U.S. News and World Report’s 2013 Best Hospitals annual rankings, which were released Tuesday, July 16, 2013.
All eligible Swedish campuses were ranked in the top 10% statewide (a total of 107 hospitals are included in the Washington survey.) Swedish/Issaquah, just entering its third year serving Eastside communities, is not yet included/eligible for the Best Hospitals rankings.
Swedish is included in two categories of rankings: